Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis

Disha Thakkar; Ranjeet Prasad Dash

doi:10.2147/DDDT.S137116

open access to scientific and medical research

Back to Journals » Drug Design, Development and Therapy » Volume 11

Letter

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis

Total article views		HTML views	PDF downloads	Totals
9,447	Dovepress*	8,911+	1,186	10,097
	PubMed Central*	536	147	683
	Totals	9,447	1,333	10,780
*Since 20 April 2017

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.